Search Videos and More
News
$25 Million Gift from Once Upon a Time Foundation Establishes Raynor Cerebellum Project at UT Southwestern to Tackle Cerebellar Dysfunction and Disorders
A generous $25 million commitment from the Once Upon a Time Foundation will create the Raynor Cerebellum Project at UT Southwestern Medical Center (RCP-UTSW) to investigate diseases associated with cerebellum dysfunction, with the goal of discovering how to preserve and restore lost brain function.
Video
Updates in Multidisciplinary Treatment of Colorectal Cancer
Experts in surgery, medical oncology, and radiation oncology describe the benefits of a multimodal approach and identify novel treatment paradigms for colorectal cancer. Watch lectures, a case-based study, and Q&A with Simmons Cancer Center physicians.
News
Lipid Nanoparticles Carry Gene-Editing Cancer Drugs Past Tumor Defenses
As they grow, solid tumors surround themselves with a thick, hard-to-penetrate wall of molecular defenses. Getting drugs past that barricade is notoriously difficult. Now, scientists at UT Southwestern have developed nanoparticles that can break down the physical barriers around tumors to reach cancer cells. Once inside, the nanoparticles release their payload: a gene editing system that alters DNA inside the tumor, blocking its growth and activating the immune system.
News
UTSW Researchers Develop Blood Test to Predict Liver Cancer Risk
Protein levels in blood samples of patients with nonalcoholic fatty liver disease reveal those at highest risk who should be screened regularly for liver cancer. Now, UT Southwestern researchers have developed a simple blood test to predict which NAFLD patients are most likely to develop liver cancer.
News
An Innovator at the Helm: Chair of Radiation Oncology Plans Big Changes
"Tumors constantly evolve, and that evolution creates opportunities for cancer to elude the ongoing therapy. No single strategy will work. We must have a treatment to uniquely fit the particular patient’s situation." -Robert Timmerman, M.D., Chair of Radiation Oncology
News
Telemedicine, Continuous Glucose Monitoring Mitigated Effects of Pandemic on Children with Diabetes
The rapid adoption of telemedicine and increased use of continuous glucose monitoring helped to attenuate the impacts of the COVID-19 pandemic on children with Type 1 diabetes, according to a new study from UT Southwestern researchers.
News
Leadership Q&A with Dr. J. William Harbour
J. William Harbour, M.D., joined UT Southwestern in November 2021 as the new Chair of Ophthalmology.
News
DOACs for LV Thrombus: The Experience from a Safety Net Hospital
An uncommon but potentially devastating complication of a cardiomyopathy is the formation of a left ventricular (LV) thrombus that embolizes and causes end-organ damage such as a stroke.
News
A Blurred Line: What’s the Distinction Between Primary and Secondary Prevention Today?
In an era of increasing use of coronary artery calcium (CAC) scanning, where asymptomatic individuals with high burdens of atherosclerosis are detected, what is the distinction between primary and secondary prevention of atherosclerotic cardiovascular disease (ASCVD)? That was the topic of a joint session between the American Society for Preventive Cardiology and AHA that I moderated at #AHA21.
News
Researchers Use Machine Learning to Identify Autism Blood Biomarkers
Using machine learning tools to analyze hundreds of proteins, UT Southwestern researchers have identified a group of biomarkers in blood that could lead to an earlier diagnosis of children with autism spectrum disorder (ASD) and, in turn, more effective therapies sooner.
News
Using Machine Learning to Predict Pediatric Brain Injury
UT Southwestern scientists have shown that a machine learning program can predict, more accurately than doctors, which babies and children are most likely to suffer brain injury after ECMO.
News
Closing in on a Cure for Duchenne Muscular Dystrophy
Using an advanced gene editing technology called CRISPR, our team of scientists at UT Southwestern has been able to stop the progression of Duchenne muscular dystrophy in animals and human cells – a breakthrough that could ultimately change the prognosis for the most common fatal genetic disease in boys.